Pressure BioSciences Inc's (OTCQB: PBIO) Global Director of Sales & Marketing Roxana McCloskey tells Proactive Investors that more than 20 journal articles describing the advantages of its pressure cycling technology (PCT) platform were published in 2018.
McCloskey says it's exciting to see these publications, including the Journal of Proteomics, issuing research on PCT and expanding the credibility of the PCT platform.
0 Comments